52
Participants
Start Date
January 1, 2027
Primary Completion Date
July 30, 2030
Study Completion Date
December 31, 2030
Intensity-modulated radiation therapy
Intensity-modulated radiation therapy (IMRT) in daily fractions of 2.67 Gy given 5 days per week for 3 weeks, for a total of 40.05 Gy.
Temozolomide
"Oral temozolomide (75 mg/m2), given 5 days per week, for 3 weeks during radiotherapy.~1 month after the discontinuation of radiotherapy, oral temozolomide is restarted at 150 to 200 mg/m2 for 5 days during each 28-day cycle for 12 cycles."
NG101m
Oral NG101m capsule continuously twice daily.
Yvonne Kew MD, PLLC, Houston
Lead Sponsor
NeuGATE Theranostics
INDUSTRY